Last reviewed · How we verify
Mucopolysaccharidosis, MPS-II
Approved treatments
- Elaprase · Shire
- Elaprase · Takeda
Elaprase works by replacing the deficient enzyme iduronate-2-sulfatase in the body.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Mucopolysaccharidosis, MPS-II patent landscape — cliff calendar, originator estates, attackable patents
- Mucopolysaccharidosis, MPS-II treatment landscape brief
- Mucopolysaccharidosis, MPS-II treatment updates RSS
Frequently asked questions about Mucopolysaccharidosis, MPS-II
What drugs treat Mucopolysaccharidosis, MPS-II?
Tracked treatments include Elaprase.
What is the treatment for Mucopolysaccharidosis, MPS-II?
Standard treatment for Mucopolysaccharidosis, MPS-II includes Elaprase. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Mucopolysaccharidosis, MPS-II patent cliff · Mucopolysaccharidosis, MPS-II CI report
- Treatment: Elaprase · Shire
- Treatment: Elaprase · Takeda
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing